Treatment of vaginal atrophy in women with cardiovascular...

Details Treatment of vaginal atrophy in women with cardiovascular... Treatment of vaginal atrophy in women with cardiovascular...

A - Human Necessities

61

K

A61K 31/566 (2006.01) A61K 9/52 (2006.01) A61P 15/02 (2006.01)

Patent

CA 2747314

The present invention relates to the use of estriol in the preparation of a pharmaceutical formulation for vaginal administration with the capacity to self-limit the absorption of estriol, for the prevention and/or the treatment of urogenital atrophy in women said women having a high probability of suffering from a cardiovascular pathology or suffering or having suffered from a cardiovascular pathology.

La présente invention concerne l'utilisation d'estriol dans la préparation d'une formulation pharmaceutique pour administration vaginale, ayant la capacité d'auto-limiter l'absorption d'estriol. Ladite préparation vise à la prévention et/ou au traitement de l'atrophie urogénitale chez des femmes présentant une probabilité élevée d'être atteintes d'une pathologie cardiovasculaire, ou de souffrir ou d'avoir souffert d'une pathologie cardiovasculaire.

Affiliated with

Also associated with

Rating

Treatment of vaginal atrophy in women with cardiovascular... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of vaginal atrophy in women with cardiovascular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of vaginal atrophy in women with cardiovascular... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1788783